Puri describes a social media post listing people who said they were curing their own cancer. He gives the example of a GitLab figure who used AI to sequence his tumor, run possible drugs through analysis, synthesize and compound them, and eventually shrink the tumor. Sam Parr adds that a friend with cancer signed up for a service of this kind and is doing well, and Puri says there are about seven other people doing the same thing.
Puri says the broader idea is that AI will be applied to science, biology and new drug development. He notes that a drug typically took 10 years and $2 billion to develop with an 80 or 90% failure rate, and that because of these numbers only drug companies of a certain size played the game.
He says Eli Lilly is leaning hard into AI, buying compute in the way tech companies do, similar to Citadel and Jane Street building their own data centers for AI in finance. He also says Google has a company called Isomorphic, whose leader, a former DeepMind founder, is now fully focused on it with the goal of curing cancer and solving large health problems. Puri concludes that now is the perfect time to build a new type of drug company or health company.
Parr says he sees this firsthand through a friend named Ben, a former producer who had a very dire outlook and posted an update that he is doing much better after reaching people in the AI community who helped connect him to resources. Puri says he watched the update and was moved by how much better Ben looks and sounds, although Ben still has cancer.